Nannoni, Stefania http://orcid.org/0000-0002-1825-1874
Maeder, Philippe
Vingerhoets, François
Michel, Patrik
Funding for this research was provided by:
European academy of Neurology (Research training fellowship 2017)
Article History
Received: 23 April 2018
Accepted: 29 June 2018
First Online: 10 July 2018
Compliance with ethical standards
:
: Stefania Nannoni reports no disclosures. Philippe Maeder reports no disclosures. François Vingerhoets reports no disclosures. Prof. Patrik Michel has received funding within the last 3 years through his institution research grants from the Swiss Heart Foundation, Boehringer-Ingelheim, and BMS; speaker fees from Boehringer-Ingelheim, Bayer, Daiichi-Sankyo, Medtronic, and Amgen; honoraria from scientific advisory boards from Boehringer-Ingelheim, Bayer, Pfizer and BMS; consulting fees from Medtronic, Astra-Zeneca, and Amgen. All this support is received by his institution (CHUV) and is used for stroke education and research.